SEOUL, July 24 (Korea Bizwire) — South Korea has granted marketing authorization to use remdesivir for coronavirus treatment, the country’s drug safety agency said Friday. The drug that is sold as Veklury and made by U.S. pharmaceutical giant Gilead Sciences Inc. contains the antiviral substance that has been shown to help COVID-19 patients, the Ministry [...]
SEOUL, July 1 (Korea Bizwire) — South Korea on Wednesday began providing remdesivir, an experimental drug conventionally used for Ebola, as a treatment drug for the novel coronavirus. The Korea Centers for Disease Control and Prevention (KCDC) said the medication developed by U.S. pharmaceutical giant Gilead Sciences Inc. will be used for COVID-19 patients with [...]
SEOUL, June 8 (Korea Bizwire) — Remdesivir shortens recovery time for novel coronavirus patients, but the experimental drug conventionally used for treating Ebola has limited efficacy in severe cases, health experts said Monday. Last week, the Ministry of Food and Drug Safety, South Korea’s drug safety watchdog, approved the use of Remdesivir as a treatment [...]
SEOUL, June 3 (Korea Bizwire) — South Korea on Wednesday approved the use of remdesivir as a treatment drug for the new coronavirus, paving the way for inbound shipments of the new drug for the first time. The Ministry of Food and Drug Safety said it has decided to allow special imports of the drug [...]
SEOUL, May 2 (Korea Bizwire) – South Korea said Saturday it is open to importing Remdesivir, an Ebola treatment that has emerged as a new hope in tackling the new coronavirus, if it proves to be effective through clinical tests. “Health authorities are working closely with related bodies to follow up on ongoing clinical tests, [...]
SEOUL, April 30 (Korea Bizwire) — South Korea will allow the use of an Ebola virus drug in treating coronavirus patients if the drug proves to be effective and safe through clinical tests, officials said Thursday. The drug, Remdesivir, has drawn keen attention since the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said [...]
SEOUL, March 3 (Korea Bizwire) — Glead Sciences’ experimental antiviral drug remdesivir is expected to be used to treat patients infected with the novel coronavirus in South Korea as part of a trial, drug industry sources said Tuesday. Remdesivir, an investigational medication developed by U.S. pharmaceutical giant Gilead Sciences Inc., was previously tested against the [...]